Teleperformance says Morgan Stanley beneficial stake falls to 5.04%
Reuters2026/08/06 16:22- Morgan Stanley cut its stake in Teleperformance below 5% of voting rights on July 30.
- Holding stood at 3,018,573 shares, equal to 5.04% of capital, 4.91% of voting rights.
- Move followed an off-market share sale.
- Position also included exposure via right-to-recall stock loans, physically settled options, cash-settled equity swaps.
- Options referenced strikes of EUR 40, EUR 50, EUR 82.78, with expiries from September 2026 to November 2029.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
